FDA Inspection 731865 — Vitalant

Vitalant — FEI 3000210247

The FDA completed an inspection of Vitalant on Jun 30, 2011 in Denver, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 30, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Denver, CO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.